Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno

Showing results (301-310 of 781) with videos related to

Pageof 79
Sort By:
The Canadian Journal of Cardiology|May 5, 2015
Managing bioabsorbable vascular scaffold failure: combined scaffold restenosis and late-acquired coronary aneurysm treated with self-expandable stentAlessio La Manna, Andrea Mangiameli, Davide Capodanno, et al.
Heart International|October 7, 2011
Atrial and ventricular function in thalassemic patients with supra-ventricular arrhythmiasInes Monte, Davide Capodanno, Elisa Nicolosi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 1, 2016
Update on clinical evidence (Part II): A summary of the main post market studiesCorrado Tamburino, Piera Capranzano, Bruno Francaviglia, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 16, 2009
Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) trial: rationale, objectives and designCorrado Tamburino, Davide Capodanno, Alessio La Manna, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 9, 2008
Early discharge in acute myocardial infarction after clinical and angiographic risk assessmentGiuseppina Branca, Davide Capodanno, Piera Capranzano, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 12, 2014
Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterizationDavide Capodanno, Margherita Ministeri, Fabio Dipasqua, et al.
Nephron Extra|April 4, 2012
Reference renal artery diameter is a stronger predictor of contrast-induced nephropathy than chronic kidney disease in patients with high cardiovascular riskLuca Zanoli, Stefania Rastelli, Carmelita Marcantoni, et al.
Heart (British Cardiac Society)|March 18, 2026
Post-acute coronary syndrome cardiovascular rehabilitation: insights into endpoints, biomarkers and clinical practiceLuigi Cutore, Denise Cristiana Faro, Carmelo Raffo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 4, 2018
Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable anginaRobert Schueler, Rasha Al-Lamee, Felix Mahfoud, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 4, 2019
The EuroIntervention health check 2019Darren Mylotte, Robert A Byrne, Davide Capodanno, et al.
Pageof 79

Showing results (301-310 of 781) with videos related to

Sort By:
Pageof 79
The Canadian Journal of Cardiology|May 5, 2015
Managing bioabsorbable vascular scaffold failure: combined scaffold restenosis and late-acquired coronary aneurysm treated with self-expandable stentAlessio La Manna, Andrea Mangiameli, Davide Capodanno, et al.
Heart International|October 7, 2011
Atrial and ventricular function in thalassemic patients with supra-ventricular arrhythmiasInes Monte, Davide Capodanno, Elisa Nicolosi, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 1, 2016
Update on clinical evidence (Part II): A summary of the main post market studiesCorrado Tamburino, Piera Capranzano, Bruno Francaviglia, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 16, 2009
Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) trial: rationale, objectives and designCorrado Tamburino, Davide Capodanno, Alessio La Manna, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 9, 2008
Early discharge in acute myocardial infarction after clinical and angiographic risk assessmentGiuseppina Branca, Davide Capodanno, Piera Capranzano, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 12, 2014
Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterizationDavide Capodanno, Margherita Ministeri, Fabio Dipasqua, et al.
Nephron Extra|April 4, 2012
Reference renal artery diameter is a stronger predictor of contrast-induced nephropathy than chronic kidney disease in patients with high cardiovascular riskLuca Zanoli, Stefania Rastelli, Carmelita Marcantoni, et al.
Heart (British Cardiac Society)|March 18, 2026
Post-acute coronary syndrome cardiovascular rehabilitation: insights into endpoints, biomarkers and clinical practiceLuigi Cutore, Denise Cristiana Faro, Carmelo Raffo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 4, 2018
Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable anginaRobert Schueler, Rasha Al-Lamee, Felix Mahfoud, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 4, 2019
The EuroIntervention health check 2019Darren Mylotte, Robert A Byrne, Davide Capodanno, et al.
Pageof 79